KSE-Listed Firms Show Strong Financial Results for Three Quarters
The 3rd quarter year-to-date (YTD) financial results for KSE-listed pharmaceutical firms, with their fiscal year ending March 2005, collectively show over 12 percent growth in revenue, propelled by aggressive marketing promotions on the leading products in the market.
According to an ana...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
